Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $414,355 - $459,011
-2,189 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$155.9 - $187.99 $59,865 - $72,188
-384 Reduced 14.92%
2,189 $408,000
Q1 2021

Apr 28, 2021

SELL
$144.0 - $169.39 $4.01 Million - $4.72 Million
-27,846 Reduced 91.54%
2,573 $405,000
Q4 2020

Feb 08, 2021

BUY
$157.07 - $174.35 $649,641 - $721,111
4,136 Added 15.74%
30,419 $5.03 Million
Q3 2020

Jan 06, 2021

BUY
$137.1 - $165.37 $649,442 - $783,357
4,737 Added 21.99%
26,283 $4.35 Million
Q2 2020

Jan 06, 2021

BUY
$111.92 - $142.53 $2.41 Million - $3.07 Million
21,546 New
21,546 $2.95 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $91.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Life Pro Asset Management Portfolio

Follow Life Pro Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Life Pro Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Life Pro Asset Management with notifications on news.